Abstract
A 31-year-old male patient with no history of cardiovascular disease collapsed during a tennis match. His tennis partner found no perceptible pulse and started CPR. Five minutes later, paramedics arrived and confirmed cardiorespiratory arrest. They performed orotracheal intubation and connected an automatic external defibrillator. This showed ventricular fibrillation, and the patient received 3 external shocks, after which sinus rhythm was restored. The patient was transported to the intensive care unit of the local hospital, where he was rapidly extubated, given his stable vital signs. History taking confirmed the absence of relevant cardiovascular disease. He was on no chronic medication at home.
His only cardiovascular risk factor was represented by overweight. He had no family history of sudden cardiac death. He denied smoking, alcohol consumption, or consumption of illicit drugs.
The ECG provided diagnostic clues for the patient’s diagnosis.
Transthoracic echocardiography showed a non-dilated LV with a preserved LV EF% of 68%, absence of LV hypertrophy, no significant valve disease, non-dilated right ventricle, absence of pericardial fluid.
An electrophysiological study was subsequently performed, confirming the diagnosis. Catheter ablation was also performed, allowing the patient to be discharged home safely. He remains symptom-free at his follow-up visits.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Brugada J, Katritsis DG, Arbelo E, Arribas F, Bax JJ, Blomstrom-Lundqvist C, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J. 2020;41(5):655–720.
Ren J, Yang Y, Zhu J, Wu S, Wang J, Zhang H, et al. The use of intravenous amiodarone in patients with atrial fibrillation and Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol. 2021;44(1):35–43.
Tijunelis MA, Herbert ME. Myth: Intravenous amiodarone is safe in patients with atrial fibrillation and Wolff-Parkinson-White syndrome in the emergency department. CJEM. 2005;7(4):262–5.
Kawabata M, Goya M, Takagi T, Yamashita S, Iwai S, Suzuki M, et al. The impact of B-type natriuretic peptide levels on the suppression of accompanying atrial fibrillation in Wolff-Parkinson-White syndrome patients after accessory pathway ablation. J Cardiol. 2016;68(6):485–91.
Pappone C, Vicedomini G, Manguso F, Baldi M, Pappone A, Petretta A, et al. Risk of malignant arrhythmias in initially symptomatic patients with Wolff-Parkinson-White syndrome: results of a prospective long-term electrophysiological follow-up study. Circulation. 2012;125(5):661–8.
Rao AL, Salerno JC, Asif IM, Drezner JA. Evaluation and management of wolff-Parkinson-white in athletes. Sports Health. 2014;6(4):326–32.
Valaparambil AK. Variability of accessory pathway refractory periods: what should be the criteria for ablation in asymptomatic wpw. Indian Pacing Electrophysiol J. 2012;12(3):79–81.
Kubus P, Vit P, Gebauer RA, Materna O, Janousek J. Electrophysiologic profile and results of invasive risk stratification in asymptomatic children and adolescents with the Wolff-Parkinson-White electrocardiographic pattern. Circ Arrhythm Electrophysiol. 2014;7(2):218–23.
Oliver C, Brembilla-Perrot B. Is the measurement of accessory pathway refractory period reproducible? Indian Pacing Electrophysiol J. 2012;12(3):93–101.
Tai CT, Chen SA, Chiang CE, Lee SH, Chang MS. Electrocardiographic and electrophysiologic characteristics of anteroseptal, midseptal, and parahisian accessory pathways. Implication for radiofrequency catheter ablation. Chest. 1996;109(3):730–40.
Plank F, Stowasser B, Till D, Schgor W, Dichtl W, Hintringer F, et al. Reduction of fluoroscopy dose for cardiac electrophysiology procedures: A feasibility and safety study. Eur J Radiol. 2019;110:105–11.
Proietti R, Abadir S, Bernier ML, Essebag V. Ablation of an atriofascicular accessory pathway with a zero-fluoroscopy procedure. J Arrhythm. 2015;31(5):323–5.
Prolic Kalinsek T, Jan M, Rupar K, Razen L, Antolic B, Zizek D. Zero-fluoroscopy catheter ablation of concealed left accessory pathway in a pregnant woman. Europace. 2017;19(8):1384.
Ramos-Maqueda J, Alvarez M, Cabrera-Ramos M, Perin F, Rodriguez-Vazquez Del Rey MDM, Jimenez-Jaimez J, et al. Results of catheter ablation with zero or near zero fluoroscopy in pediatric patients with supraventricular tachyarrhythmias. Rev Esp Cardiol. 2021;75(2):166–73.
Scaglione M, Ebrille E, Caponi D, Siboldi A, Bertero G, Di Donna P, et al. Zero-fluoroscopy ablation of accessory pathways in children and adolescents: CARTO3 electroanatomic mapping combined with rf and cryoenergy. Pacing Clin Electrophysiol. 2015;38(6):675–81.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Halbwachs, F., Tissier, M., Lawson, A., Bouillard, R. (2022). Case 11. In: Muresan, L. (eds) Clinical Cases in Cardiac Electrophysiology: Supraventricular Arrhythmias. Springer, Cham. https://doi.org/10.1007/978-3-031-07357-1_11
Download citation
DOI: https://doi.org/10.1007/978-3-031-07357-1_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-07356-4
Online ISBN: 978-3-031-07357-1
eBook Packages: MedicineMedicine (R0)